Dr. Lakshmi Narayanan

Mississippi State University, USA

Email: lna45@msstate.edu

Qualifications

2012 Ph.D., Biological Sciences, Mississippi State University, USA

2005 M.Sc., Biomedical Genetics, Vellore Institute of Technology, India

Publications (Selected)

1. Ünlü, E. S., Narayanan, L. and Gordon, D. M. (2013), Characterization of fungal RTG2 genes in retrograde signaling of Saccharomyces cerevisiae. FEMS Yeast Research, 13: 495–503.
2. Narayanan, L., Mukherjee, D., Zhang, S., Yu, B. and Chevalier, D. (2014) Mutational Analyses of a Fork Head Associated Domain Protein, DAWDLE, in Arabidopsis thaliana. American Journal of Plant Sciences, 5, 2811-2822.
3. Narayanan LA and Edelmann MJ (2014). Ubiquitination as an efficient molecular strategy employed in Salmonella infection. Front. Immunol. 5: 558.
4. Coyne C, Narayanan L. (2015) Fludarabine-(C2-methylhydroxyphosphoramide)-[anti-IGF-1R]: Synthesis and Selectively “Targeted” Anti-Neoplastic Cytotoxicity against Pulmonary Adenocarcinoma (A549). Journal of Pharmaceutics & Drug Delivery research.;4(1): 129.
5. Coyne, C. P., & Narayanan, L. (2016). Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549). Drug Design, Development and Therapy, 10, 2575–2597.
6. Coyne, C. P. and Narayanan, L. (2016), Gemcitabine-(5′-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549). Chem Biol Drug Des.